Bio Pharma Dive
APRIL 26, 2022
Apertura Gene Therapy, a new company formed by Deerfield, is hoping a suite of next-generation tools will help it stand out at a time when this area of research has fallen out of favor with some public investors.
BioPharma Reporter
APRIL 26, 2022
Valneva and Pfizer report positive Phase 2 pediatric data for their Lyme disease vaccine candidate, VLA15: and now plan to include this population in an upcoming Phase 3 trial.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
APRIL 26, 2022
Loss of the lucrative partnership has triggered a wide-ranging restructuring that will pare down Nektar’s workforce by about 70%.
pharmaphorum
APRIL 26, 2022
Compared to a ‘critical organ’ that had been largely ignored, companies working to develop microbiome-based therapies believe there is untapped potential in the area. Ben Hargreaves speaks to companies that are developing therapies not just in gastrointestinal conditions but also in broader areas, such an immuno-oncology. The interest in how the human microbiome influences health has grown substantially in the last decade.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
APRIL 26, 2022
Novartis said in an earnings presentation Tuesday that it hired biotech analyst Ronny Gal as chief strategy and growth officer and revealed more details about planned layoffs as the company restructures.
Scienmag
APRIL 26, 2022
Globally, the prevalence of type 2 diabetes mellitus (T2DM) is increasing. A study publishing April 26th in the open access journal PLOS Medicine by Marisa Miraldo at Imperial College Business School, London, United Kingdom, and colleagues suggests that living near fast food restaurants increases the risk of developing Type 2 diabetes. Credit: Yalinda De Almeida […].
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Scienmag
APRIL 26, 2022
The high efficiency, light weight and flexibility of the latest solar cell technology means photovoltaics could provide all the power needed for an extended mission to Mars, or even a permanent settlement there, according to a new analysis by scientists at the University of California, Berkeley. Most scientists and engineers who’ve thought about the logistics […].
pharmaphorum
APRIL 26, 2022
Making sure clinical trials are diverse and representative of the populations they’re studying isn’t just the right thing to do to promote inclusivity and equity; it’s also just good science/clinical scientific practice. But despite growing efforts to improve, many organisers still fall short when it comes to reaching, recruiting and retaining diverse patient populations in clinical trials.
Intouch Solutions
APRIL 26, 2022
Intouch was awarded the “Best Rare Disease Campaign” at the 33rd annual Med Ad News Manny Awards on April 22, a recognition for the “Kind to Each Other – Fierce Against MD” campaign for Kindness Over Muscular Dystrophy. The goal of the campaign was to increase awareness about Duchenne muscular dystrophy (DMD). DMD is an incurable and fatal genetic disorder that gradually weakens the body’s muscles, and affects one in 5,000 newborn babies, primarily boys.
Pharma Times
APRIL 26, 2022
Follow-on collaboration between ViGeneron and Daiichi Sankyo allows the companies to create and validate vgAAV-based therapeutic candidates
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Drug Patent Watch
APRIL 26, 2022
Annual Drug Patent Expirations for INVEGA+TRINZA Invega Trinza is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There is one…. The post New patent for Janssen Pharms drug INVEGA TRINZA appeared first on DrugPatentWatch - Make Better Decisions.
pharmaphorum
APRIL 26, 2022
French drugmaker wants the efficiency of its manufacturing operations to go up a gear, and has joined forces with Formula One racing team McLaren to make it happen. The multi-year partnership will see McLaren work with Sanofi’s industrial affairs team, using its digital and analytics expertise to look at the pharma company’s manufacturing operations and find ways to improve efficiency.
Pharma Times
APRIL 26, 2022
The Foundation also launched a new collaboration with Diabetes UK and the Juvenile Diabetes Research Foundation UK
XTalks
APRIL 26, 2022
California-based startup Air Protein developed an alt meat called Air Meat, which is made using microbes that turn recycled carbon dioxide (CO2) into protein. Described by the company as “the meat of tomorrow,” Air Meat was designed to replicate the flavor and texture of real meat products like chicken, pork, steak and seafood. So, how does the company make alt protein out of thin air?
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
APRIL 26, 2022
Preparing for surgery can be a scary, momentous occasion in any person’s life, but a greater chance of danger because of skin color should not be part of the equation. The South Carolina Surgical Quality Collaborative (SQC) was created in 2015 to level the playing field for surgical patients, and a recent study conducted at […].
Outsourcing Pharma
APRIL 26, 2022
The companyâs Precision Olfactory Delivery technology, currently combined with its Trudhesa migraine treatment, reportedly facilitates high absorption rates.
Scienmag
APRIL 26, 2022
When the global community is expected to meet for the second part of the UN Biodiversity Conference in Kunming, China, in autumn, it must also adopt the next generation of UN biodiversity targets. These will then replace the Aichi Targets that were aimed for until 2020 – and have hardly been achieved. 21 “Post-2020 Action […].
Drug Channels
APRIL 26, 2022
Baseball season is in full swing! Oil up your glove, lace up your cleats, and let's run the bases around this month's news stories. Remember: Sometimes you win, sometimes you lose, and sometimes it rains. In this issue: Green Monster : The 340B market hits new highs in 2021 Not-Free Agents : Big 340B profits for CVS, Walgreens, Express Scripts, et al Batter Up : Fixing the insulin market Pinch Hitters : Walgreens bets on robots Plus, Dr.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
APRIL 26, 2022
You may assume that metropolitan areas are devoid of wildlife, but that is very far from the truth. The remaining green spaces within the urban matrices of large cities can serve as corridors or stepping stones for wild animals. Sometimes, even threatened mammal species end up using them. Credit: Diego Floriano da Rocha, Thaís Brauner […].
pharmaphorum
APRIL 26, 2022
There’s only one vaccine candidate for tick-borne infection Lyme disease in clinical development – Valneva and Pfizer’s VLA15 – and it has just moved another step closer to being available. The two partners have reported positive results in a phase 2 trial in paediatric patients aged five to 17, backing up earlier results in adults and setting up the start of a pivotal phase 3 trial in the third quarter of this year.
Scienmag
APRIL 26, 2022
Pregnancy brings deep changes in women’s physiology, especially regarding her blood system. The placenta is the organ which ensures an efficient communication between the mother and the baby. This organ grows quickly and links a significant quantity of mother’s blood supply to the fetus’. Thus, placenta has a relevant impact on blood pressure and it […].
Fossil Remedies
APRIL 26, 2022
PCD Pharma Business Plan. In a pharmaceutical business, you need a link between the pharma marketing company and the end-user, i.e., doctors, pharmacists, or others who can prescribe the medicine. This connecting link is the PCD Pharma Business. The full form of PCD is Propaganda Cum Distribution. Are you a person who wants to know about the details of preparing a successful PCD pharma business plan?
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
APRIL 26, 2022
Catalysts are tricky things, but without them, our world would be a lot dirtier. Credit: Tom Cogill/University of Virginia School of Engineering and Applied Science Catalysts are tricky things, but without them, our world would be a lot dirtier. Catalysts – materials that accelerate chemical reactions – are used to save energy, reduce waste and […].
NY Times
APRIL 26, 2022
Moderna and the Pfizer-BioNTech partnership are developing versions of their coronavirus vaccines for children under 5, with emergency-use filings expected in the next several weeks.
Scienmag
APRIL 26, 2022
Cognitive development in children could be affected regardless of which biological parent has type 1 diabetes, according to research publishing April 19th in the open access journal PLOS Medicine. The research shows for the first time that having a parent with a chronic disease like type 1 diabetes may be associated with lower school performance […].
BioPharma Reporter
APRIL 26, 2022
CDMO Scorpion Biological Services will build a new biodefense-focused large molecule and biologics biomanufacturing facility in Manhattan, Kansas.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
APRIL 26, 2022
A University of Texas at Arlington computer scientist is exploring how to integrate materials like clay, silicone, glass, biomaterials and textiles with 3D-printing technologies. Credit: UT Arlington A University of Texas at Arlington computer scientist is exploring how to integrate materials like clay, silicone, glass, biomaterials and textiles with 3D-printing technologies.
Intouch Solutions
APRIL 26, 2022
Intouch was awarded the “Best Rare Disease Campaign” at the 33rd annual Med Ad News Manny Awards on April 22, a recognition for the “Kind to Each Other – Fierce Against MD” campaign for Kindness Over Muscular Dystrophy. The goal of the campaign was to increase awareness about Duchenne muscular dystrophy (DMD). DMD is an incurable and fatal genetic disorder that gradually weakens the body’s muscles, and affects one in 5,000 newborn babies, primarily boys.
Scienmag
APRIL 26, 2022
Microplastics are a pathway for pathogens on land to reach the ocean, with likely consequences for human and wildlife health, according to a study from the University of California, Davis. Credit: Karen Shapiro, UC Davis Microplastics are a pathway for pathogens on land to reach the ocean, with likely consequences for human and wildlife health, […].
The Pharma Data
APRIL 26, 2022
Sanofi announces today that it is partnering with McLaren Racing to accelerate manufacturing efficiency and performance in support of the company’s ambition to attain world-class standards of manufacturing excellence. Following a successful pilot in 2021 with McLaren Racing, both companies have decided to extend their collaboration across multiple sites in seven countries, covering more than 100 production lines, across all technologies.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
246 
Let's personalize your content